Loading organizations...
Evonik Venture Capital is the corporate venture capital arm of Evonik Industries, a leading specialty chemicals company. It strategically invests in technology funds and startups whose solutions align with Evonik’s core segments, like sustainable chemistry and advanced materials. It identifies and integrates disruptive technologies, enhancing the parent company’s product portfolio and market capabilities.
Established by Evonik Industries, the unit emerged from a corporate strategy to proactively source external innovation. This initiative complements Evonik's internal R&D, providing a pathway to capitalize on emerging technologies. Its creation underscores commitment to securing future growth and leadership in industrial chemistry.
Evonik Venture Capital supports portfolio companies with capital and partnership, delivering insights and growth opportunities to Evonik Industries. The unit's vision is to generate strategic value, accelerating Evonik's position as a best-in-class specialty chemicals provider. External innovation contributes to the parent company’s long-term sustainability and market competitiveness.
Key people at Evonik Venture Capital.
Evonik Venture Capital has 9 tracked investments across 7 companies. The latest tracked deal is $38.0M Series B in Velox in April 2024.
Key people at Evonik Venture Capital.